Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) reported Total revenues for the second quarter of 2015 were $333.7 million, an increase of 15% over total revenues of $291.2 million for the second quarter of 2014. The increase in total revenues was driven by higher net product sales of Xyrem® (sodium oxybate) oral solution. Total revenues include net product sales, royalties and contract revenues. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) belongs to Healthcare sector. Its net profit margin is 18.00% and weekly performance is 0.64%. On last trading day company shares ended up $191.90. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) distance from 50-day simple moving average (SMA50) is 6.07%.
Comstock Resources Inc. (NYSE:CRK) reported a net loss of $135.1 million or $2.93 per share for the second quarter of 2015 as compared to net income of $1.9 million or 4¢ per diluted share for the second quarter of 2014. The second quarter 2015 results include a loss related to the previously announced sale of the Company’s Burleson County, Texas properties, which closed on July 22, 2015, of $111.8 million ($72.7 million after tax or $1.58 per share). Comstock Resources Inc. (NYSE:CRK) shares advanced 20.20% in last trading session and ended the day at $1.19. CRK Gross Margin is 80.50% and its return on assets is -5.80%. Comstock Resources Inc. (NYSE:CRK) quarterly performance is -75.00%.
On 05 August, Methode Electronics, Inc. (NYSE:MEI) shares decreased -0.15% and was closed at $26.43. MEI EPS growth in last 5 year was 47.30%. Methode Electronics, Inc. (NYSE:MEI) year to date (YTD) performance is -27.05%.
CVS’s Health Corporation (NYSE:CVS) net income rose 2.1 percent to $1.27 billion, or $1.12 per share, in the quarter ended June. Net revenue rose 7.4 percent to $37.17 billion. Excluding items, CVS earned $1.22 per share. Analysts on average had expected earnings of $1.20 per share and revenue of $37.18 billion, according to Thomson Reuters I/B/E/S. CVS Health Corporation (NYSE:CVS) ended the last trading day at $111.20. Company weekly volatility is calculated as 1.74% and price to cash ratio as 76.79. CVS Health Corporation (NYSE:CVS) showed a weekly performance of -1.98%.
H&R Block, Inc. (NYSE:HRB) announced that H&R Block, H&R Block Bank and BofI have received regulatory approvals from the Office of the Comptroller of the Currency (OCC) and the Board of Governors of the Federal Reserve System (Federal Reserve) to proceed with the purchase and assumption agreement previously announced on April 10, 2014. H&R Block, Inc. (NYSE:HRB) shares advanced 8.91% in last trading session and ended the day at $35.83. HRB Gross Margin is 66.20% and its return on assets is 11.90%. H&R Block, Inc. (NYSE:HRB) quarterly performance is 19.39%.